The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients

被引:0
|
作者
Doreen Z. Mhandire
Andrew K. L. Goey
机构
[1] Roswell Park Comprehensive Cancer Center,Department of Pharmacology and Therapeutics
来源
Molecular Diagnosis & Therapy | 2022年 / 26卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Many anticancer drugs cause adverse drug reactions (ADRs) that negatively impact safety and reduce quality of life. The typical narrow therapeutic range and exposure-response relationships described for anticancer drugs make precision dosing critical to ensure safe and effective drug exposure. Germline mutations in pharmacogenes contribute to inter-patient variability in pharmacokinetics and pharmacodynamics of anticancer drugs. Patients carrying reduced-activity or loss-of-function alleles are at increased risk for ADRs. Pretreatment genotyping offers a proactive approach to identify these high-risk patients, administer an individualized dose, and minimize the risk of ADRs. In the field of oncology, the most well-studied gene-drug pairs for which pharmacogenetic dosing recommendations have been published to improve safety are DPYD-fluoropyrimidines, TPMT/NUDT15-thiopurines, and UGT1A1-irinotecan. Despite the presence of these guidelines, the scientific evidence showing the benefits of pharmacogenetic testing (e.g., improved safety and cost-effectiveness) and the development of efficient multi-gene genotyping panels, routine pretreatment testing for these gene-drug pairs has not been implemented widely in the clinic. Important considerations required for widespread clinical implementation include pharmacogenetic education of physicians, availability or allocation of institutional resources to build an efficient clinical infrastructure, international standardization of guidelines, uniform adoption of guidelines by regulatory agencies leading to genotyping requirements in drug labels, and development of cohesive reimbursement policies for pretreatment genotyping. Without clinical implementation, the potential of pharmacogenetics to improve patient safety remains unfulfilled.
引用
收藏
页码:137 / 151
页数:14
相关论文
共 50 条
  • [41] Drug-related illness in emergency department patients
    Dennehy, CE
    Kishi, DT
    Louie, C
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (12) : 1422 - 1426
  • [42] Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients
    Chan, Alexandre
    Soh, Deren
    Ko, Yu
    Huang, Yu-Chu
    Chiang, Joen
    SUPPORTIVE CARE IN CANCER, 2014, 22 (07) : 1875 - 1881
  • [43] When is a drug-related death not a drug-related death? Implications for current drug-related death policies in the UK and Europe
    Beynon, Caryl M.
    Bellis, Mark A.
    Church, Elaine
    Neely, Sue
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2007, 2 (1)
  • [44] When is a drug-related death not a drug-related death? Implications for current drug-related death policies in the UK and Europe
    Caryl M Beynon
    Mark A Bellis
    Elaine Church
    Sue Neely
    Substance Abuse Treatment, Prevention, and Policy, 2
  • [45] How search engines may help reduce drug-related suicides
    Haim, Mario
    Scherr, Sebastian
    Arendt, Florian
    DRUG AND ALCOHOL DEPENDENCE, 2021, 226
  • [46] In-hospital medication reviews reduce unidentified drug-related problems
    Åsa Bondesson
    Tommy Eriksson
    Annika Kragh
    Lydia Holmdahl
    Patrik Midlöv
    Peter Höglund
    European Journal of Clinical Pharmacology, 2013, 69 : 647 - 655
  • [47] HOW CLOUDS CAN REDUCE DRUG-RELATED HARM: THE BLUEBELLY PROJECT
    Stephens, Ray
    DRUG AND ALCOHOL REVIEW, 2009, 28 : A60 - A60
  • [48] Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity
    Prado, Carla M. M.
    Antoun, Sami
    Sawyer, Michael B.
    Baracos, Vickie E.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2011, 14 (03): : 250 - 254
  • [50] DRUG-RELATED DEMENTIA
    PASSARELLA, B
    NOZZOLI, C
    GIORNALE DI NEUROPSICOFARMACOLOGIA, 1993, 15 (04): : 159 - 163